Compare Centratama Telekomunikasi Indonesia Tbk. (CENT) vs Ikapharmindo Putramas Tbk. (IKPM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Centratama Telekomunikasi Indonesia Tbk. vs Ikapharmindo Putramas Tbk. — how do they compare? Centratama Telekomunikasi Indonesia Tbk. trades at Rp74 (market cap 2.34T, 535.2K 24h volume), while Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 304.92B, 13.7K 24h volume). The key difference: Centratama Telekomunikasi Indonesia Tbk. is far larger — about 7.7× Ikapharmindo Putramas Tbk.'s market cap, and Centratama Telekomunikasi Indonesia Tbk. is more actively traded (535.2K versus 13.7K). Which is the better fit depends on your goals.
| CENT | IKPM | |
|---|---|---|
Market Cap | 2.34T | 304.92B |
Volume | 535.2K | 13.7K |
Lot | 5.35K | 137 |
Turnover | 39.66M | 2.49M |
Average Price | 74.1 | 181.39 |
Value | 39.66M | 2.49M |
Indicative Equilibrium Price | 74 | — |
Indicative Equilibrium Volume | 527 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Centratama Telekomunikasi Indonesia Tbk.
PT Centratama Telekomunikasi Indonesia Tbk formerly Centrin Online The corporate was established on February 11th 1987 in Bandung as PT. Centrindo Utama. Since the first establishment, corporate focus the business on the information technology. Start the operation in computer hardware sales such as supporting hardware and monitor which produced by PT. Central Rama Informatiko as a affiliated company. And start the internet service provider business on 1996.
Read more on CENT →About Ikapharmindo Putramas Tbk.
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →
